Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calazime is an over-the-counter (OTC) topical skin protectant paste manufactured by Medline Industries. It is formulated as a combination of active ingredients including zinc oxide, calamine, menthol, and white petrolatum. The product functions primarily as a physical barrier to protect the skin from moisture and irritants, while also drying light exudates from compromised skin. It is indicated for the treatment and prevention of diaper rash, minor skin irritations, and the relief of discomfort associated with macerated skin conditions. The inclusion of menthol provides a cooling sensation to soothe irritated areas. Calazime is widely used in clinical and long-term care settings for the management of incontinence-associated dermatitis and other moisture-related skin damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calazime.